7-Ethyl-10-hydroxycamptothecin - 98%, high purity , CAS No.86639-52-3

Item Number
E110128
Grouped product items
SKUSizeAvailabilityPrice Qty
E110128-100mg
100mg
In stock
$94.90
E110128-500mg
500mg
In stock
$177.90
E110128-1g
1g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$320.90
E110128-5g
5g
In stock
$1,441.90

DNA topoisomerase I inhibitor. Active metabolite of CPT-11.

Basic Description

SynonymsUNII-0H43101T0J | BCP9000200 | 0H43101T0J | BP-24513 | CAMPTOTHECIN, 7-ETHYL-10-HYDROXY- | SN 38 lactone | AC-1357 | NCGC00167831-05 | Q-200299 | (S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione | GTPL6925 | 1H-
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsActive metabolite of irinotecan. Inhibitor of topoisomerase I.. Gene expression analysis of colon cancer cell lines treated with SN-38 showed differential effects: the majority of affected genes were down-regulated (including, most strongly, genes related
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Associated Targets(Human)

TOP1 Tclin DNA topoisomerase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABCG2 Tchem ATP-binding cassette sub-family G member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488187375
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488187375
IUPAC Name (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
INCHI InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1
InChi Key FJHBVJOVLFPMQE-QFIPXVFZSA-N
Canonical SMILES CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O
Isomeric SMILES CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O
WGK Germany 3
RTECS UQ0491000
Alternate CAS 86639-52-3
PubChem CID 104842
NSC Number 673596
MeSH Entry Terms 7 Ethyl 10 hydroxycamptothecin;7-ethyl-10-hydroxycamptothecin;Camptosar;Camptothecin 11;camptothecin-11;CPT 11;CPT-11;CPT11;irinotecan;irinotecan hydrochloride;Irrinotecan;NK012 compound;SN 38;SN 38 11;SN-38;SN-38-11;SN3811
Molecular Weight 392.4
Reaxy-Rn 4829984

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

13 results found

Lot NumberCertificate TypeDateItem
I1926046Certificate of AnalysisJul 14, 2023 E110128
B2317760Certificate of AnalysisJan 07, 2023 E110128
B2317761Certificate of AnalysisJan 07, 2023 E110128
B2317767Certificate of AnalysisJan 07, 2023 E110128
B2317778Certificate of AnalysisJan 07, 2023 E110128
B2317803Certificate of AnalysisJan 07, 2023 E110128
B2317820Certificate of AnalysisJan 07, 2023 E110128
B2317862Certificate of AnalysisJan 07, 2023 E110128
I2207459Certificate of AnalysisJul 29, 2022 E110128
I2207460Certificate of AnalysisJul 29, 2022 E110128
I2207461Certificate of AnalysisJul 29, 2022 E110128
I2207462Certificate of AnalysisJul 29, 2022 E110128
K2327037Certificate of AnalysisJul 29, 2022 E110128

Show more⌵

Chemical and Physical Properties

Sensitivityheat sensitive
Specific Rotation[α]+20.0 to +30.0 deg(C=0.2, THF)
Melt Point(°C)217°C

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS08
Signal Danger
Hazard Statements

H301:Toxic if swallowed

H341:Suspected of causing genetic defects

Precautionary Statements

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P281:Use personal protective equipment as required.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

P318:if exposed or concerned, get medical advice.

WGK Germany 3
RTECS UQ0491000
Reaxy-Rn 4829984

Related Documents

Citations of This Product

1. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu.  (2023)  Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.  BIOMATERIALS,  301  (122259).  [PMID:37531777] [10.1016/j.biomaterials.2023.122259]
2. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang.  (2023)  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.  International Journal of Nanomedicine,      [PMID:28553107] [10.2147/IJN.S134005]
3. Jinjin Chen, Lulu Zhou, Chunhui Wang, Yunhao Sun, Yonglin Lu, Ruihao Li, Xiaochun Hu, Mengyao Chen, Lv Chen, Keke Chai, Tianming Yao, Shuo Shi, Chunyan Dong.  (2020)  A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer.  Nanoscale,  12  (41): (21234-21247).  [PMID:33063070] [10.1039/D0NR06266A]
4. Hua Sun, Xiaotong Zhou, Baojian Wu.  (2015)  Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.  XENOBIOTICA,  45  (11): (945-953).  [PMID:26068529] [10.3109/00498254.2015.1033502]

References

1. Peter S et al..  (2016)  Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I..  Nucleic Acids Res,      [PMID:27587582]
2. Winkler C et al..  (2021)  SLFN11 informs on standard of care and novel treatments in a wide range of cancer models..  Br J Cancer,  124  (5): (951-962).  [PMID:33339894]
3. Lili Cheng, Peng Zhang, Yadong Liu, Zhuoyin Liu, Junjie Tang, Langtao Xu, Jie Liu.  (2023)  Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.  BIOMATERIALS,  301  (122259).  [PMID:37531777] [10.1016/j.biomaterials.2023.122259]
4. Linjie Yang, Jingyi Hong, Jing Di, Yifei Guo, Meihua Han, Meifeng Liu, Xiangtao Wang.  (2023)  10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.  International Journal of Nanomedicine,      [PMID:28553107] [10.2147/IJN.S134005]
5. Jinjin Chen, Lulu Zhou, Chunhui Wang, Yunhao Sun, Yonglin Lu, Ruihao Li, Xiaochun Hu, Mengyao Chen, Lv Chen, Keke Chai, Tianming Yao, Shuo Shi, Chunyan Dong.  (2020)  A multifunctional SN38-conjugated nanosystem for defeating myelosuppression and diarrhea induced by irinotecan in esophageal cancer.  Nanoscale,  12  (41): (21234-21247).  [PMID:33063070] [10.1039/D0NR06266A]
6. Hua Sun, Xiaotong Zhou, Baojian Wu.  (2015)  Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.  XENOBIOTICA,  45  (11): (945-953).  [PMID:26068529] [10.3109/00498254.2015.1033502]

Solution Calculators